Reduced expression of transforming growth factor ß1 exacerbates pathology in an experimental asthma model

Scherf W, Burdach S, Hansen G (2005)
Eur.J.Immunol 35(1): 198-206.

Download
No fulltext has been uploaded. References only!
Journal Article | English

No fulltext has been uploaded

Author
; ;
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Scherf W, Burdach S, Hansen G. Reduced expression of transforming growth factor ß1 exacerbates pathology in an experimental asthma model. Eur.J.Immunol. 2005;35(1):198-206.
Scherf, W., Burdach, S., & Hansen, G. (2005). Reduced expression of transforming growth factor ß1 exacerbates pathology in an experimental asthma model. Eur.J.Immunol, 35(1), 198-206. doi:10.1002/eji.200425209
Scherf, W., Burdach, S., and Hansen, G. (2005). Reduced expression of transforming growth factor ß1 exacerbates pathology in an experimental asthma model. Eur.J.Immunol 35, 198-206.
Scherf, W., Burdach, S., & Hansen, G., 2005. Reduced expression of transforming growth factor ß1 exacerbates pathology in an experimental asthma model. Eur.J.Immunol, 35(1), p 198-206.
W. Scherf, S. Burdach, and G. Hansen, “Reduced expression of transforming growth factor ß1 exacerbates pathology in an experimental asthma model”, Eur.J.Immunol, vol. 35, 2005, pp. 198-206.
Scherf, W., Burdach, S., Hansen, G.: Reduced expression of transforming growth factor ß1 exacerbates pathology in an experimental asthma model. Eur.J.Immunol. 35, 198-206 (2005).
Scherf, Wiebke, Burdach, S., and Hansen, G. “Reduced expression of transforming growth factor ß1 exacerbates pathology in an experimental asthma model”. Eur.J.Immunol 35.1 (2005): 198-206.
This data publication is cited in the following publications:
This publication cites the following data publications:

41 Citations in Europe PMC

Data provided by Europe PubMed Central.

TGFB1 promoter polymorphism C-509T and pathophysiology of asthma.
Ueda T, Niimi A, Matsumoto H, Takemura M, Yamaguchi M, Matsuoka H, Jinnai M, Chin K, Minakuchi M, Cheng L, Shirakawa T, Mishima M., J Allergy Clin Immunol 121(3), 2008
PMID: 18036644
Transforming growth factor-beta regulates house dust mite-induced allergic airway inflammation but not airway remodeling.
Fattouh R, Midence NG, Arias K, Johnson JR, Walker TD, Goncharova S, Souza KP, Gregory RC, Lonning S, Gauldie J, Jordana M., Am J Respir Crit Care Med 177(6), 2008
PMID: 18174546
The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity.
Whitehead GS, Wang T, DeGraff LM, Card JW, Lira SA, Graham GJ, Cook DN., Am J Respir Crit Care Med 175(3), 2007
PMID: 17095748
Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease.
Locke NR, Royce SG, Wainewright JS, Samuel CS, Tang ML., Am J Respir Cell Mol Biol 36(5), 2007
PMID: 17237192
Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease.
Alcorn JF, Rinaldi LM, Jaffe EF, van Loon M, Bates JH, Janssen-Heininger YM, Irvin CG., Am J Respir Crit Care Med 176(10), 2007
PMID: 17761617
The involvement of type 1a angiotensin II receptors in the regulation of airway inflammation in a murine model of allergic asthma.
Ohwada K, Watanabe K, Okuyama K, Ohkawara Y, Sugaya T, Takayanagi M, Ohno I., Clin Exp Allergy 37(11), 2007
PMID: 17877756
Controversy surrounding the increased expression of TGF beta 1 in asthma.
Bossé Y, Rola-Pleszczynski M., Respir Res 8(), 2007
PMID: 17892594
Smad3 -signalling and Th2 cytokines in normal mouse airways and in a mouse model of asthma.
Anthoni M, Wang G, Leino MS, Lauerma AI, Alenius HT, Wolff HJ., Int J Biol Sci 3(7), 2007
PMID: 18071588
Targeting memory Th2 cells for the treatment of allergic asthma.
Epstein MM., Pharmacol Ther 109(1-2), 2006
PMID: 16081161
Transforming growth factor-beta regulation of immune responses.
Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA., Annu Rev Immunol 24(), 2006
PMID: 16551245
[Eosinophilic inflammation in bronchial asthma: its re-evaluation].
Fujisawa T., Nihon Naika Gakkai Zasshi 95(8), 2006
PMID: 16955945
T regulatory cells in allergen-specific immunotherapy.
Verhagen J, Taylor A, Blaser K, Akdis M, Akdis CA., Int Rev Immunol 24(5-6), 2005
PMID: 16318994

56 References

Data provided by Europe PubMed Central.

Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene.
Geiser AG, Zeng QQ, Sato M, Helvering LM, Hirano T, Turner CH., Bone 23(2), 1998
PMID: 9701466
Increased levels of surgical adhesions in TGFbeta1 heterozygous mice.
Krause TJ, Katz D, Wheeler CJ, Ebner S, McKinnon RD., J Invest Surg 12(1), 1999
PMID: 10084677
Cutaneous wound healing.
Singer AJ, Clark RA., N. Engl. J. Med. 341(10), 1999
PMID: 10471461
TGF-beta and fibrosis.
Branton MH, Kopp JB., Microbes Infect. 1(15), 1999
PMID: 10611762
Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography.
Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW., Am. J. Respir. Crit. Care Med. 156(3 Pt 1), 1997
PMID: 9309991

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 15593298
PubMed | Europe PMC

Search this title in

Google Scholar